ExpreS2ion Biotech Holding AB (publ) filed its Annual on May 02, 2023 for the period ending Dec 31, 2022. In this report its auditor, Ernst & Young LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.058 SEK | -8.32% |
|
-7.19% | -49.86% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-49.86% | 5.58M | |
+6.58% | 39.05B | |
-11.57% | 33.74B | |
+79.15% | 28.54B | |
-14.73% | 15.59B | |
-6.00% | 13.69B | |
-12.55% | 11.44B | |
+166.50% | 10.66B | |
-54.80% | 9.27B | |
+4.19% | 9.13B |
- Stock Market
- Equities
- EXPRS2 Stock
- News ExpreS2ion Biotech Holding AB
- ExpreS2ion Biotech Holding AB Auditor Raises 'Going Concern' Doubt